Latest filing published 19 Nov 2025 for LENZ Therapeutics, Inc., €18k. Read the official filing
Shawn Olsson discloses dealings in LENZ Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 16 December 2024 to 17 November 2025, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 19 November 2025, reports an option exercise of €18k in LENZ Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations